ubenimex has been researched along with HIV Coinfection in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borkowsky, W; Bourinbaiar, AS; Krasinski, K; Lee-Huang, S | 1 |
Fukushima, J; Hamajima, K; Ishii, N; Mohri, H; Okuda, K; Sasaki, S; Tsuji, T; Xin, KQ | 1 |
Brown, R; Conway, B; Izaguirre, CA; Proulx, P; Pulido-Cejudo, G | 1 |
Mathé, G | 1 |
Bygbjerg, IC; Dalh Christensen, L; Faber, V; Gøtzsche, PC; Hørding, M | 1 |
1 review(s) available for ubenimex and HIV Coinfection
Article | Year |
---|---|
Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function.
Topics: Aminopeptidases; Animals; Antibiotics, Antineoplastic; HIV Infections; Humans; Leucine; Mice; Neoplasms; Neoplasms, Experimental | 1991 |
1 trial(s) available for ubenimex and HIV Coinfection
Article | Year |
---|---|
Double-blind trial of bestatin in HIV-positive patients.
Topics: Adjuvants, Immunologic; Aminopeptidases; Double-Blind Method; HIV Infections; HIV Seropositivity; Humans; Leucine; Male | 1990 |
3 other study(ies) available for ubenimex and HIV Coinfection
Article | Year |
---|---|
Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.
Topics: Anti-Bacterial Agents; CD4-Positive T-Lymphocytes; Cell Division; Cell-Free System; Dextran Sulfate; HIV; HIV Infections; Immunity, Cellular; Immunologic Factors; In Vitro Techniques; Leucine; Virus Replication; Zidovudine | 1994 |
Adjuvant effect of Ubenimex on a DNA vaccine for HIV-1.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Animals; HIV Infections; Humans; Injections, Intramuscular; Leucine; Mice; Mice, Inbred BALB C; Vaccines, DNA | 1998 |
Bestatin-mediated inhibition of leucine aminopeptidase may hinder HIV infection.
Topics: Anti-HIV Agents; Cytopathogenic Effect, Viral; HIV; HIV Core Protein p24; HIV Infections; Humans; Leucine; Leucyl Aminopeptidase; Protease Inhibitors; Protein Kinase C; Tumor Cells, Cultured | 1997 |